Bio-Active Riboflavin
Natural health product licensed in Canada
- Other names
- Bio-Active B2, Bio-B2, Cyto-Active B2, Cyto-Active Riboflavin, Cyto-B2
- Licence holder
- Cyto-Matrix Inc.
- NPN or DIN-HM
- 80101439
- Status
- Inactive licence
- Licence date
- 5 June 2020
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Riboflavine Source : Riboflavine 5'-phosphate | 100 mg | 100,000 µg |
Non-medicinal ingredients
Stéarate de magnésium, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Helps in energy metabolism and in tissue formation. Helps to maintain healthy mucous membranes. Helps to maintain normal red blood cells. Helps to maintain normal metabolism of iron. Helps to prevent riboflavin deficiency. Helps to maintain the body's ability to metabolize nutrients. Helps to maintain the body's ability to metabolize nutrients and helps in tissue formation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80101439
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.